SCHEMBL8209772

SCHEMBL8209772

CCC(c1c2ccccc2cc2ccccc12)c1c2ccccc2cc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CYP1A2 P05177 4/20 0.42
ALDH1A1 P00352 3/20 0.42
HSD17B10 Q99714 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HPGD P15428 2/20 0.42
KDM4E B2RXH2 1/20 0.42
GLA P06280 1/20 0.42
CYP2C19 P33261 1/20 0.42
GPR84 Q9NQS5 1/20 0.40
HIF1A Q16665 1/20 0.39
CYP1B1 Q16678 1/20 0.39
CYP2A6 P11509 1/20 0.39
AKR1B1 P15121 1/20 0.37
CYP3A4 P08684 1/20 0.36
ERBB2 P04626 1/20 0.36
FYN P06241 1/20 0.36
MAOA P21397 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8211958 0.83 NQO1 (0.45) HTR2AL3MBTL1CYP1A2ALDH1A1HSD17B10
SCHEMBL18949976 0.81 HTR2A (0.42) HTR2AL3MBTL1CYP1A2ALDH1A1HSD17B10
SCHEMBL8207670 0.80 MAPT (0.43) HTR2AL3MBTL1MEN1KMT2AKDM4E
SCHEMBL8211957 0.80 TACR3 (0.42) HTR2AL3MBTL1CYP1A2ALDH1A1HSD17B10
SCHEMBL243405 0.79 LMNA (0.47) HTR2AL3MBTL1CYP1A2ALDH1A1HSD17B10
SCHEMBL28050927 0.79 HTR2A (0.41) HTR2AL3MBTL1CYP1A2ALDH1A1HSD17B10
SCHEMBL10361949 0.79 MAPT (0.45) L3MBTL1MEN1KMT2AKDM4E
SCHEMBL6266749 0.78 KDM4E (0.53) CYP1A2ALDH1A1HSD17B10KMT2AHPGD
SCHEMBL4019719 0.76 MEN1 (0.54) CYP1A2ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL1610411 0.75 HTR2A (0.37) HTR2AL3MBTL1CYP1A2ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0979078-A4 SUBSTITUTED BIS-ACRIDINES AND RELATED COMPOUNDS AS CCR5 RECEPTOR LIGANDS, ANTI-INFLAMMATORY AGENTS AND ANTI-VIRAL AGENTS SMITHKLINE BEECHAM CORP (US) 2000-06-21 EP claimed
EP-0979078-A1 SUBSTITUTED BIS-ACRIDINES AND RELATED COMPOUNDS AS CCR5 RECEPTOR LIGANDS, ANTI-INFLAMMATORY AGENTS AND ANTI-VIRAL AGENTS SMITHKLINE BEECHAM CORPORATION (US) 2000-02-16 EP claimed
WO-1998030218-A1 SUBSTITUTED BIS-ACRIDINES AND RELATED COMPOUNDS AS CCR5 RECEPTOR LIGANDS, ANTI-INFLAMMATORY AGENTS AND ANTI-VIRAL AGENTS SMITHKLINE BEECHAM CORPORATION (US) 1998-07-16 WO claimed
EP-0979078-A4 SUBSTITUTED BIS-ACRIDINES AND RELATED COMPOUNDS AS CCR5 RECEPTOR LIGANDS, ANTI-INFLAMMATORY AGENTS AND ANTI-VIRAL AGENTS SMITHKLINE BEECHAM CORP (US) 2000-06-21 EP disclosed
EP-0979078-A1 SUBSTITUTED BIS-ACRIDINES AND RELATED COMPOUNDS AS CCR5 RECEPTOR LIGANDS, ANTI-INFLAMMATORY AGENTS AND ANTI-VIRAL AGENTS SMITHKLINE BEECHAM CORPORATION (US) 2000-02-16 EP disclosed
WO-1998030218-A1 SUBSTITUTED BIS-ACRIDINES AND RELATED COMPOUNDS AS CCR5 RECEPTOR LIGANDS, ANTI-INFLAMMATORY AGENTS AND ANTI-VIRAL AGENTS SMITHKLINE BEECHAM CORPORATION (US) 1998-07-16 WO disclosed